Italy allows the reintroduction of sibutramine

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Adverse Event Obesity Internal Medicine Medicinal Product Cardiac Adverse Event

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1358(2002), 1 vom: Okt., Seite 21-21
Übergeordnetes Werk:	volume:1358 ; year:2002 ; number:1 ; month:10 ; pages:21-21

Links:	Volltext

DOI / URN:	10.2165/00128413-200213580-00047

Katalog-ID:	SPR035140267

Internformat


LEADER	01000caa a22002652 4500
001	SPR035140267
003	DE-627
005	20230519203429.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213580-00047 \|2 doi
035			\|a (DE-627)SPR035140267
035			\|a (SPR)00128413-200213580-00047-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Italy allows the reintroduction of sibutramine
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Adverse Event \|7 (dpeaa)DE-He213
650		4	\|a Obesity \|7 (dpeaa)DE-He213
650		4	\|a Internal Medicine \|7 (dpeaa)DE-He213
650		4	\|a Medicinal Product \|7 (dpeaa)DE-He213
650		4	\|a Cardiac Adverse Event \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1358(2002), 1 vom: Okt., Seite 21-21 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1358 \|g year:2002 \|g number:1 \|g month:10 \|g pages:21-21
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213580-00047 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1358 \|j 2002 \|e 1 \|c 10 \|h 21-21

Indexfelder

matchkey_str	article:22306056:2002----::tlalwteenrdcinf
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213580-00047 doi (DE-627)SPR035140267 (SPR)00128413-200213580-00047-e DE-627 ger DE-627 rakwb eng Italy allows the reintroduction of sibutramine 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1358(2002), 1 vom: Okt., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1358 year:2002 number:1 month:10 pages:21-21 https://dx.doi.org/10.2165/00128413-200213580-00047 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1358 2002 1 10 21-21
spelling	10.2165/00128413-200213580-00047 doi (DE-627)SPR035140267 (SPR)00128413-200213580-00047-e DE-627 ger DE-627 rakwb eng Italy allows the reintroduction of sibutramine 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1358(2002), 1 vom: Okt., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1358 year:2002 number:1 month:10 pages:21-21 https://dx.doi.org/10.2165/00128413-200213580-00047 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1358 2002 1 10 21-21
allfields_unstemmed	10.2165/00128413-200213580-00047 doi (DE-627)SPR035140267 (SPR)00128413-200213580-00047-e DE-627 ger DE-627 rakwb eng Italy allows the reintroduction of sibutramine 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1358(2002), 1 vom: Okt., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1358 year:2002 number:1 month:10 pages:21-21 https://dx.doi.org/10.2165/00128413-200213580-00047 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1358 2002 1 10 21-21
allfieldsGer	10.2165/00128413-200213580-00047 doi (DE-627)SPR035140267 (SPR)00128413-200213580-00047-e DE-627 ger DE-627 rakwb eng Italy allows the reintroduction of sibutramine 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1358(2002), 1 vom: Okt., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1358 year:2002 number:1 month:10 pages:21-21 https://dx.doi.org/10.2165/00128413-200213580-00047 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1358 2002 1 10 21-21
allfieldsSound	10.2165/00128413-200213580-00047 doi (DE-627)SPR035140267 (SPR)00128413-200213580-00047-e DE-627 ger DE-627 rakwb eng Italy allows the reintroduction of sibutramine 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1358(2002), 1 vom: Okt., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1358 year:2002 number:1 month:10 pages:21-21 https://dx.doi.org/10.2165/00128413-200213580-00047 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1358 2002 1 10 21-21
language	English
source	Enthalten in Inpharma weekly 1358(2002), 1 vom: Okt., Seite 21-21 volume:1358 year:2002 number:1 month:10 pages:21-21
sourceStr	Enthalten in Inpharma weekly 1358(2002), 1 vom: Okt., Seite 21-21 volume:1358 year:2002 number:1 month:10 pages:21-21
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Adverse Event Obesity Internal Medicine Medicinal Product Cardiac Adverse Event
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035140267
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035140267</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203429.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213580-00047</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035140267</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213580-00047-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Italy allows the reintroduction of sibutramine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Event</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicinal Product</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiac Adverse Event</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1358(2002), 1 vom: Okt., Seite 21-21</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1358</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:21-21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213580-00047</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1358</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">21-21</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Italy allows the reintroduction of sibutramine Adverse Event (dpeaa)DE-He213 Obesity (dpeaa)DE-He213 Internal Medicine (dpeaa)DE-He213 Medicinal Product (dpeaa)DE-He213 Cardiac Adverse Event (dpeaa)DE-He213
topic	misc Adverse Event misc Obesity misc Internal Medicine misc Medicinal Product misc Cardiac Adverse Event
spellingShingle	misc Adverse Event misc Obesity misc Internal Medicine misc Medicinal Product misc Cardiac Adverse Event Italy allows the reintroduction of sibutramine
topic_unstemmed	misc Adverse Event misc Obesity misc Internal Medicine misc Medicinal Product misc Cardiac Adverse Event
topic_browse	misc Adverse Event misc Obesity misc Internal Medicine misc Medicinal Product misc Cardiac Adverse Event
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Italy allows the reintroduction of sibutramine
ctrlnum	(DE-627)SPR035140267 (SPR)00128413-200213580-00047-e
title_full	Italy allows the reintroduction of sibutramine
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	21
container_volume	1358
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213580-00047
title_sort	italy allows the reintroduction of sibutramine
title_auth	Italy allows the reintroduction of sibutramine
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Italy allows the reintroduction of sibutramine
url	https://dx.doi.org/10.2165/00128413-200213580-00047
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213580-00047
up_date	2024-07-03T13:43:42.935Z
_version_	1803565633832484864
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035140267</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203429.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213580-00047</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035140267</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213580-00047-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Italy allows the reintroduction of sibutramine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Event</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicinal Product</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiac Adverse Event</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1358(2002), 1 vom: Okt., Seite 21-21</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1358</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:21-21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213580-00047</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1358</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">21-21</subfield></datafield></record></collection>
score	7.401292

Nicht das Richtige dabei?

Schreiben Sie uns!

Italy allows the reintroduction of sibutramine

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?